Orlando Sentinel (Free subscription) | 07/20/2008
For four years, Sarah Kerlin, 10, has been battling one brain tumor after another. She has spent nearly half her life undergoing surgeries, radiation and chemotherapy, and now she faces a brain tumor doctors say is inoperable.
Orlando Sentinel (Free subscription) | 07/20/2008
For four years, Sarah Kerlin, 10, has been battling one brain tumor after another. She has spent nearly half her life undergoing surgeries, radiation and chemotherapy, and now she faces a brain tumor doctors say is inoperable.
Curing Death by Curing Aging (Free subscription) | 07/19/2008
Researchers a step closer to delivering cancer-killing drugs to pediatric brain tumors
I Am A TV Junkie, A Blog For The Cl (Free subscription) | 07/18/2008
I kinda feel guilty, not too guilty to go to the "Katherine Heigl has a big mouth" well for another post, but guilty because I don't even watch this show....
WCBSTV.com: Your Source For New Yor (Free subscription) | 07/16/2008
While many musicians follow notes on a page, jazz artists are known to improvise most of their tunes. Researchers are using a tool normally used to find brain tumors to figure out how they do it, leading to a new understanding of the brain.
Daily Tech (Free subscription) | 07/16/2008
It's looking pretty bad for cancer these days thanks to our friend nanotechnology.
The Liberal Blog Network (Free subscription) | 07/16/2008
An in-trial dendritic cell vaccine that fights malignant brain tumors called glioblastoma multiforme (GBM) may help boost a patient's immunity response and improve the outcome, a new report says.
kansascity.com (Free subscription) | 07/16/2008
The Environmental Protection Agency and the Missouri Department of Natural Resources collected soil samples Tuesday up in Cameron, Mo., to be tested for contaminates. The tests come after a number of area children were diagnosed with brain tumors.
Physorg (Free subscription) | 07/15/2008
Researchers conducting a clinical trial of a dendritic cell vaccine designed to fight malignant brain tumors called glioblastoma multiforme (GBM) have found a correlation between the "intensity" of a patient's immune response and clinical outcome, according to an article in the July 15 issue of the journal Cancer Research.
Medical News Today (Free subscription) | 07/15/2008
An interdisciplinary team of researchers at Washington University in St. Louis, led by Karen L. Wooley, Ph.D., James S. McDonnell Distinguished University Professor in Arts & Sciences, is a step closer to delivering cancer-killing drugs to pediatric brain tumors, similar to the tumor that Senator Ted Kennedy is suffering from.
Medical News Today (Free subscription) | 07/15/2008
Researchers conducting a clinical trial of a dendritic cell vaccine designed to fight malignant brain tumors called glioblastoma multiforme (GBM) have found a correlation between the "intensity" of a patient's immune response and clinical outcome, according to an article in the July 15 issue of the journalCancer Research.
Science Daily (Free subscription) | 07/15/2008
Researchers conducting a clinical trial of a dendritic cell vaccine designed to fight malignant brain tumors called glioblastoma multiforme have found a correlation between the "intensity" of a patient's immune response and clinical outcome, according to an article in the journal Cancer Research.
Eurekalert (Free subscription) | 07/15/2008
Researchers conducting a clinical trial of a dendritic cell vaccine designed to fight malignant brain tumors called glioblastoma multiforme have found a correlation between the "intensity" of a patient's immune response and clinical outcome, according to an article in the July 15 issue of the journal Cancer Research.
Newswise (Free subscription) | 07/15/2008
Researchers conducting a clinical trial of a dendritic cell vaccine designed to fight malignant brain tumors called glioblastoma multiforme (GBM) have found a correlation between the "intensity" of a patient's immune response and clinical outcome, according to an article in the July 15 issue of the journal Cancer Research.
Nanotechnology News from Nanowerk (Free subscription) | 07/14/2008
Slow release of nanoparticles is key.
